Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.41
Handel nachbörslich:
.35
0.35
+
Schlusskurs vom Vortag:
$0.41
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$2.15M
Einnahmen:
$4.17M
Nettoeinkommen (Verlust:
$-27.71M
KGV:
0.00
EPS:
-0.37
Netto-Cashflow:
$-22.23M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$15.82
Clearside Biomedical Inc Stock (CLSD) Company Profile
Firmenname
Clearside Biomedical Inc
Sektor
Branche
Telefon
678-270-3631
Adresse
900 NORTH POINT PARKWAY, ALPHARETTA, GA
Compare CLSD vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLSD
Clearside Biomedical Inc
|
0.00 | 2.15M | 4.17M | -27.71M | -22.23M | -0.37 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.27 | 123.47B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
766.66 | 83.60B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
748.72 | 46.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
318.65 | 43.11B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
297.04 | 34.79B | 4.98B | 69.60M | 525.67M | 0.5198 |
Clearside Biomedical Inc Stock (CLSD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-18 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2025-07-18 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-07-18 | Herabstufung | Stifel | Buy → Hold |
| 2024-08-21 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-06-25 | Eingeleitet | Oppenheimer | Outperform |
| 2021-12-15 | Fortgesetzt | Wedbush | Outperform |
| 2021-07-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-05-13 | Eingeleitet | ROTH Capital | Buy |
| 2019-08-09 | Herabstufung | Needham | Buy → Hold |
| 2018-11-05 | Herabstufung | Cowen | Outperform → Market Perform |
| 2018-11-05 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2018-11-05 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-06 | Bestätigt | Needham | Buy |
| 2017-05-25 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2017-02-24 | Eingeleitet | JP Morgan | Overweight |
| 2016-11-10 | Bestätigt | Needham | Buy |
| 2016-10-24 | Bestätigt | Stifel | Buy |
Alle ansehen
Clearside Biomedical Inc Aktie (CLSD) Neueste Nachrichten
Market Wrap: Is Clearside Biomedical Inc a momentum stockJuly 2025 News Drivers & Expert Approved Trade Ideas - baoquankhu1.vn
Downgrade Watch: Should I hold or sell Clearside Biomedical Inc now2025 Stock Rankings & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Clearside Bio Wants Block On $100M Bid That 'Froze' Auction - Law360
Gainers Report: Is Clearside Biomedical Inc stock good for income investorsTrade Entry Summary & Short-Term High Return Ideas - baoquankhu1.vn
Uveitis Clinical Trial Pipeline Expands as 15+ Companies Advance 15+ Targeted Ocular Inflammation Therapies Toward Market Entry, Finds DelveInsight | Santen, Clearside Biomedical, Tarsier Pharma - Barchart.com
Uveitis Clinical Trial Pipeline Expands as 15+ Companies - openPR.com
Aug Volume: Will Clearside Biomedical Inc benefit from geopolitical trendsNew Guidance & Consistent Income Trade Recommendations - baoquankhu1.vn
Can Clearside Biomedical Inc. stock attract ESG capital inflowsJuly 2025 Breakouts & Low Drawdown Investment Strategies - mfd.ru
Treasury Yields: How much upside does Clearside Biomedical Inc haveWeekly Investment Summary & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Will Clearside Biomedical Inc. benefit from geopolitical trendsJuly 2025 Final Week & Consistent Profit Trade Alerts - mfd.ru
Clearside Biomedical’s Asset Sale Faces Shareholder Resistance - AD HOC NEWS
Block Trades: Should I hold or sell Clearside Biomedical Inc nowJuly 2025 Levels & Consistent Growth Stock Picks - baoquankhu1.vn
Clearside Biomedical’s Final Chapter: Asset Sale Nears Completion - AD HOC NEWS
Big Money Moves: Will Clearside Biomedical Inc benefit from geopolitical trendsEarnings Recap Summary & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Clearside Biomedical Shares Surge Amid Bankruptcy Proceedings - AD HOC NEWS
Big Picture: What dividend growth rate does Clearside Biomedical Inc offerJuly 2025 Opening Moves & Community Verified Trade Alerts - baoquankhu1.vn
Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
Insider Sell: How does Verde Clean Fuels Inc Equity Warrant compare to its peers2025 Major Catalysts & Smart Investment Allocation Tips - baoquankhu1.vn
Should I buy Clearside Biomedical Inc stock nowJuly 2025 PostEarnings & Free Community Supported Trade Ideas - baoquankhu1.vn
Should I hold or sell Clearside Biomedical Inc stock in 2025Market Trend Report & Weekly Setup with ROI Potential - Bộ Nội Vụ
Travel Stocks: Should I hold or sell Clearside Biomedical Inc stock in 2025M&A Rumor & Reliable Entry Point Alerts - Bộ Nội Vụ
CLSDClearside Biomedical Announces First Quarter 2020 Financial Results - ADVFN
How Clearside Biomedical Inc. stock reacts to bond yieldsJuly 2025 Trends & Growth Focused Stock Pick Reports - ulpravda.ru
Why Clearside Biomedical Inc. (CLM) stock is upgraded to buy2025 Market Sentiment & Free Expert Approved Momentum Trade Ideas - Улправда
Published on: 2026-01-09 22:57:41 - bollywoodhelpline.com
Clearside Biomedical, Inc. (NASDAQ:CLSD) Receives Average Rating of “Hold” from Brokerages - Defense World
Will Clearside Biomedical Inc. stock benefit from infrastructure spendingJuly 2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - Улправда
Will Clearside Biomedical Inc. stock outperform international peersTrade Exit Report & Daily Chart Pattern Signals - Улправда
Investment Report: Will Clearside Biomedical Inc. stock outperform international peersRate Cut & Precise Swing Trade Alerts - Улправда
Published on: 2026-01-09 03:39:24 - Улправда
Will Clearside Biomedical Inc. stock benefit from AI adoptionEarnings Growth Report & High Accuracy Buy Signal Tips - Улправда
How Clearside Biomedical Inc. (CLM) stock behaves in tightening cyclesJuly 2025 Sector Moves & Fast Gaining Stock Reports - Улправда
How Clearside Biomedical Inc. stock benefits from global expansionPortfolio Growth Summary & Smart Swing Trading Alerts - Улправда
What market sentiment indicators show for Clearside Biomedical Inc. (CLM) stockResistance Breakout Alerts & Test Our Stock Screener — Free Forever - Улправда
Growth Value: Why pension funds invest in Clearside Biomedical Inc CLM stock2025 Big Picture & Stepwise Entry and Exit Trade Signals - moha.gov.vn
Published on: 2026-01-03 17:03:18 - moha.gov.vn
Clearside Biomedical receives court approval for asset sale bidding procedures By Investing.com - Investing.com Nigeria
Clearside Biomedical receives court approval for asset sale bidding procedures - Investing.com India
Clearside Biomedical Advances Bankruptcy Asset Sale Process - TipRanks
Clearside Biomedical (CLSDQ) - Zacks Investment Research
What date does Clearside Biomedical's (CLSDQ) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
Should I buy Clearside Biomedical (CLSDQ) - Zacks Investment Research
Published on: 2025-12-22 07:38:00 - moha.gov.vn
Can Clearside Biomedical Inc. stock maintain growth trajectoryJuly 2025 Recap & Low Drawdown Investment Strategies - Улправда
Would You Still Hold Clearside Biomedical Stock If It Fell Another 30%? - Trefis
Why Clearside Biomedical Inc. stock remains on buy lists2025 Biggest Moves & Precise Buy Zone Tips - Улправда
Published on: 2025-12-20 02:04:19 - Улправда
Biomedical Co. Gets Approval For Ch. 11 Auction In January - Law360
Will Clearside Biomedical Inc. stock pay special dividendsWeekly Stock Summary & Low Risk High Reward Trade Ideas - DonanımHaber
Published on: 2025-12-18 17:06:04 - Улправда
Bidding Procedure Approved for Clearside Biomedical, Inc. - marketscreener.com
Finanzdaten der Clearside Biomedical Inc-Aktie (CLSD)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.71%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):